Ball Corporation vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

Ball Corporation leads in AI visibility (94 vs 90)

Ball Corporation

LeaderManufacturing

Enterprise

Westminster CO world aluminum can leader (NYSE: BALL) at $11.8B 2024 sales; sold Ball Aerospace to BAE for $5.6B in 2024, new CEO Lewis, and $4B buyback with ReAl alloy innovation competing with Crown Holdings for beverage packaging.

AI VisibilityBeta
Overall Score
A94
Category Rank
#236 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
91
Perplexity
90
Gemini
97

About

Ball Corporation is a Westminster, Colorado-based aluminum packaging manufacturer — publicly traded on the New York Stock Exchange (NYSE: BALL) as an S&P 500 component — operating as the world's leading provider of aluminum beverage cans, aerosol cans, and personal care packaging with 16,000+ employees across 65+ manufacturing plants worldwide. In fiscal year 2024, Ball reported net sales of $11.80 billion and a market capitalization of approximately $12.85 billion. In 2025, Ball appointed Ronald J. Lewis as the 13th CEO in the company's 145-year history (effective immediately), succeeding the previous leadership; Lewis previously served as Ball's Chief Supply Chain and Operations Officer since 2024 and joined Ball in 2019 as President of the Europe, Middle East and Asia beverage business. Ball completed a transformative strategic milestone in 2024 by divesting Ball Aerospace to BAE Systems for $5.6 billion in cash, enabling Ball to focus exclusively on its core aluminum packaging business. Ball also announced a $4 billion share buyback program in 2025 and returned $1.96 billion to shareholders in 2024. Founded in 1880 as a glass jar manufacturer, Ball innovated the ReAl alloy aerosol can — 15% lighter than standard cans with only half the carbon footprint.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

94
Overall Score
90
#236
Category Rank
#9
71
AI Consensus
60
stable
Trend
stable
91
ChatGPT
99
90
Perplexity
99
97
Gemini
83
99
Claude
96
88
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.